Sipos, B;
Hahn, D;
Carceller, A;
Piulats, J;
Hedderich, J;
Kalthoff, H;
Goodman, S L;
Kosmahl, M;
Klöppel, G
Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro
Contributor:
Sipos, B;
Hahn, D;
Carceller, A;
Piulats, J;
Hedderich, J;
Kalthoff, H;
Goodman, S L;
Kosmahl, M;
Klöppel, G
Description:
<jats:p><jats:bold>Aims</jats:bold> : To analyse the expression of α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>, an epithelial integrin involved in wound healing and tumorigenesis, in various human carcinoma types.</jats:p><jats:p><jats:bold>Methods and results</jats:bold> : A new monoclonal antibody to the human β<jats:sub>6</jats:sub> subunit, 5C4, was used to locate α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> in 157 cancers of gastroenteropancreatic and 21 of lung origin. The data were validated by analysis of α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> extracted from histological sections. α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> integrin showed strongest expression in 34 pancreatic ductal adenocarcinomas (mean score 2.88 ± 0.52), followed by 24 intestinal‐type gastric carcinomas (1.45 ± 1.06) and eight lung adenocarcinomas (1.37 ± 1.1). Moderate expression was found in 31 diffuse‐type gastric carcinomas (0.94 ± 0.83), seven duodenal adenocarcinomas (0.8 ± 1.34) and 26 colorectal adenocarcinomas (0.76 ± 0.71). Little α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> was seen in seven liver cell carcinomas and six neuroendocrine tumours. Well‐differentiated carcinomas expressed more β<jats:sub>6</jats:sub> than poorly differentiated tumours. Peritumoral epithelial tissues where α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>‐expressing tumours arose also expressed α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>. There was no correlation between expression of α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> and its ligands tenascin and fibronectin in pancreatic and gastric carcinomas. Spheroid formation by pancreatic carcinoma cell lines led to α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> up‐regulation, but appeared independent of classical ligand binding to α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>.</jats:p><jats:p><jats:bold>Conclusions</jats:bold> : Our findings indicate that: (i) α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> is overexpressed in pancreatic adenocarcinomas; (ii) α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>‐positive carcinomas originate from α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub>‐expressing tissues; (iii) α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> expression in tumours seems to be regulated independently from that of its ligands tenascin and fibronectin; and (iv) <jats:italic>in‐vitro</jats:italic> overexpression of α<jats:sub>v</jats:sub>β<jats:sub>6</jats:sub> in pancreatic carcinoma cell lines accompanies spheroid formation.</jats:p>